USFDA completes inspection of API facility of Cadila Healthcare Ltd


Mumbai,  Pharma Major Cadila Healthcare said that USFDA inspected Company's API manufacturing facility located at Ankleshwar from July 22 to July 26, 2019.  This audit covered both Unit I and II. At the end of the inspection, no observation (483) was issued.

Opinions expressed in the comments are not reflective of Central Chronicle. Comments are moderated automatically.